Capricor Therapeutics shares are trading higher after the company announced it signed an exclusive, worldwide licensing agreement with Johns Hopkins University to expand its exosome platform technolog
Capricor Therapeutics shares are trading higher after the company announced it signed an exclusive, worldwide licensing agreement with Johns Hopkins University to expand its exosome platform technolog
Capricor Treateutics股价上涨，此前该公司宣布与约翰·霍普金斯大学(Johns Hopkins University)签署了一项独家的全球许可协议，以扩大其外体平台Technolog
Capricor Therapeutics shares are trading higher after the company announced it signed an exclusive, worldwide licensing agreement with Johns Hopkins University to expand its exosome platform technology portfolio.
Capricor Treateutics的股价上涨，此前该公司宣布与约翰·霍普金斯大学(Johns Hopkins University)签署了一项独家的全球许可协议，以扩大其Exosome平台技术组合。